Dextera Surgical Inc (NASDAQ:DXTR) shares traded -5.22% down during most recent session to reach at the closing price of $0.31. The stock exchanged hands 2.98 Million shares versus average trading capacity of 7.47 Million shares, yielding a market cap of $2.9 Million. Wall Street analysts covering the stock are projecting that the stock will reach $0.73 within the next 52-weeks. The mean target projections are based on 3 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Dextera Surgical Inc (NASDAQ:DXTR) high price target of $0.8 and with a conservative view have low price target of $0.7.
Ladenburg Thalmann “Initiates Coverage On” Dextera Surgical Inc (NASDAQ:DXTR) in a research note issued to investors on 8/16/17 to Buy with price target of $0.8.
Additionally on 7/12/17 Wedbush “Maintained” Dextera Surgical Inc (NASDAQ:DXTR) to Outperform setting price target at $0.7.
On the other hand the company has Relative Strength Index (RSI 14) of 55.02 along with Average True Range (ATR 14) of 0.03, Consequently Dextera Surgical Inc (NASDAQ:DXTR)’s weekly and monthly volatility is 16.45%, 10.40% respectively. The company’s beta value is at -1.12.
In terms of Buy, Sell or Hold recommendations, Dextera Surgical Inc (NASDAQ:DXTR) has analysts’ mean recommendation of 1.7. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Dextera Surgical Inc (NASDAQ:DXTR)’s minimum EPS for the current quarter is at $-0.09 and can go high up to $-0.05. The consensus mean EPS for the current quarter is at $-0.07 derived from a total of 2 estimates from the analysts who have weighed in on projected earnings. However the company reported $-0.44 earnings per share for the same quarter during last year.
Previously Dextera Surgical Inc (NASDAQ:DXTR) reported $-0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.11 by $-0.06. The company posted an earnings surprise of -54.5%.
Dextera Surgical Inc (NASDAQ:DXTR)’s revenue estimates for the current quarter are $1.11 Million according to 2 number of analysts, for the current quarter the company has high revenue estimates of $1.4 Million in contradiction of low revenue estimates of $830 Million. For the current year the company’s revenue estimates are $5.76 Million compared to low analyst estimates of $5.19 Million and high estimates of $6.33 Million according to 2 number of analysts.
Currently Dextera Surgical Inc (NASDAQ:DXTR)’s shares owned by insiders are 0%, whereas shares owned by institutional owners are 39.7%. However the six-month change in the insider ownership was recorded 0%, as well as three-month change in the institutional ownership was recorded 16.12%.
Dextera Surgical Inc (NASDAQ:DXTR) 52-week high price stands at $2.36 and low price stands at $0.17, its price distance from 52-week high is -87.08% while its distance from 52-week low price is 79.41%. The stock hit its 52-week high on 01/11/17, and 52-week low on 05/30/17.
Dextera Surgical Inc (NASDAQ:DXTR)’s trailing twelve month revenues are $3.4 Million, whereas its price to sales ratio for the same period is 0.85. Its book value per share for the most recent quarter is $0.01 while its price to book ratio for the same period is 30.5, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.